logo

9.55

9.55 (0.75%)

As of Mar 06, 2024

Oncternal Therapeutics, Inc. [ONCT]

Source: 

Company Overview

Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies for cancers with critical unmet medical need. Our development efforts are focused on promising, yet untapped, biological pathways implicated in cancer generation or progression.

CountryUnited States
Headquarterssan diegocalifornia
Phone Number(858) 434-1113
Industry
manufacturing
CEOJames B. Breitmeyer
Websitewww.clinicaltrials.gov